WHITMORE BRADFORD T — SEC Form 4 filings
SEC reporting owner CIK 933430. 16 Form 4 filings on record with FilingPulse; latest filed 2026-05-26.
Transaction summary — filings shown
Covers all 16 filings on record, filed 2024-02-09 to 2026-05-26. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 25 legs across 11 filings — 11,469,402 shares, $33,381,531 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 2 legs across 1 filing — 6,689,000 shares, $28,093,800 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 3.
- Largest priced transaction: purchase of 4,189,000 shares @ $4.20 ($17,593,800) in SOLESENCE, INC., filed 2025-06-02.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| SOLESENCE, INC. (SLSN) | 10% owner | 5 | 6 legs · 10,513,864 sh · $29,623,746 | 2 legs · 6,689,000 sh · $28,093,800 | 2 |
| ULTRALIFE CORP (ULBI) | Director, 10% owner | 10 | 18 legs · 511,094 sh · $3,157,786 | — | — |
| Clearside Biomedical, Inc. (CLSD) | 10% owner | 1 | 1 leg · 444,444 sh · $599,999 | — | 1 |
Form 4 filings — WHITMORE BRADFORD T
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-05-26 | 4 | ULTRALIFE CORP (ULBI) | Purchase (P): 32,876 @ $6.13 · Purchase (P): 8,700 @ $6.33 · Purchase (P): 67,302 @ $6.81 | EDGAR |
| 2026-03-16 | 4 | ULTRALIFE CORP (ULBI) | Purchase (P): 33,741 @ $5.97 · Purchase (P): 100,640 @ $6.32 · Purchase (P): 53,131 @ $6.76 | EDGAR |
| 2026-01-05 | 4 | ULTRALIFE CORP (ULBI) | Holdings only — no transactions reported | EDGAR |
| 2025-12-16 | 4 | ULTRALIFE CORP (ULBI) | Purchase (P): 9,530 @ $5.63 · Purchase (P): 14,882 @ $5.66 · Purchase (P): 28,588 @ $5.70 | EDGAR |
| 2025-11-21 | 4 | ULTRALIFE CORP (ULBI) | Purchase (P): 53,900 @ $4.97 | EDGAR |
| 2025-08-21 | 4 | ULTRALIFE CORP (ULBI) | Purchase (P): 15,898 @ $6.56 · Purchase (P): 13,000 @ $6.57 · Purchase (P): 29,766 @ $6.63 | EDGAR |
| 2025-06-13 | 4 | ULTRALIFE CORP (ULBI) | Purchase (P): 10,000 @ $7.64 | EDGAR |
| 2025-06-02 | 4 | SOLESENCE, INC. (SLSN) | Purchase (P): 2,500,000 @ $4.20 · Purchase (P): 4,189,000 @ $4.20 · Sale (S): 2,500,000 @ $4.20 · Sale (S): 4,189,000 @ $4.20 | EDGAR |
| 2025-05-28 | 4 | ULTRALIFE CORP (ULBI) | Purchase (P): 11,980 @ $5.41 | EDGAR |
| 2025-05-15 | 4 | ULTRALIFE CORP (ULBI) | Purchase (P): 8,957 @ $5.40 · Purchase (P): 16,063 @ $5.47 · Purchase (P): 2,140 @ $5.72 | EDGAR |
| 2024-09-03 | 4 | ULTRALIFE CORP (ULBI) | Holdings only — no transactions reported | EDGAR |
| 2024-09-03 | 4 | NANOPHASE TECHNOLOGIES Corp (NANX) | Holdings only — no transactions reported | EDGAR |
| 2024-06-26 | 4 | NANOPHASE TECHNOLOGIES Corp (NANX) | Conversion (C): 15,000,000 @ $0 | EDGAR |
| 2024-03-05 | 4 | NANOPHASE TECHNOLOGIES Corp (NANX) | Purchase (P): 15,000 (derivative) @ $400 | EDGAR |
| 2024-02-12 | 4 | NANOPHASE TECHNOLOGIES Corp (NANX) | Purchase (P): 2,791,725 @ $0.40 · Purchase (P): 952,697 @ $0.40 · Purchase (P): 74,105 @ $0.40 · Purchase (P): 6,337 @ $0.40 | EDGAR |
| 2024-02-09 | 4 | Clearside Biomedical, Inc. (CLSD) | Purchase (P): 444,444 @ $1.35 · Purchase (P): 444,444 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=933430 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →